Sebastian Siegner
PhD Student
Sebastian Siegner received his MSc in Biochemistry from ETH Zurich in December 2020 with his work on the therapeutic potential of CRISPR Base- and Prime-Editors for the genetic disease Fanconi Anemia. In 2021 Sebastian returned as a PhD student, focusing on genetic interactions in the human DNA damage response. His researches interests include functional genomics, DNA repair and therapeutic gene editing.
